Table 1.

Clinical features of tumors and association with CLDN4 expression level (n = 139).

Feature	CLDN4		p value
	Low	High
Sex (M/F)	97/5	35/2	0.905
Survival (A/D)	18/84	0/37	0.006 *
Recurrence (Y/N)	63/39	26/11	0.356
Stage (I–IIb/III–IVB)	41/58	13/22	0.658
Age (mean ± SD)	56.31 ± 10.80	57.89 ± 12.43	0.466
Survival month (mean ± SD)	40.46 ± 46.69	18.13 ± 9.88	0.005 #
Recurrence month (mean ± SD)	33.67 ± 47.20	11.12 ± 7.91	0.005 #

^*Chi-squared; ^#Student’s t test.

F, female; M, male;